World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
138
Citations
75784
World Ranking
1825
National Ranking
1042

Overview

Robert J. Mayer is affiliated with the Dana-Farber Cancer Institute in the United States, contributing to research in both medicine and chemistry. Their scholarly output includes publications across several intersecting fields, centering predominantly on oncology and organic chemistry.

The main fields of study in their work include:

  • Medicine
  • Chemistry

Within these broader areas, Mayer's research touches on multiple subfields such as:

  • Organic Chemistry
  • Oncology
  • Materials Chemistry
  • Molecular Biology
  • Pathology and Forensic Medicine

Their primary research topics cover a range of specialized subjects, notably:

  • Colorectal Cancer Treatments and Studies
  • Crystallization and Solubility Studies
  • X-ray Diffraction in Crystallography
  • Genetic Factors in Colorectal Cancer
  • Gastric Cancer Management and Outcomes
  • Asymmetric Synthesis and Catalysis
  • Colorectal Cancer Screening and Detection

Mayer has authored multiple peer-reviewed papers, including the following representative works:

  • NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020, published in 2020 in the Journal of the National Comprehensive Cancer Network
  • Lewis Acidity Scale of Diaryliodonium Ions toward Oxygen, Nitrogen, and Halogen Lewis Bases, published in 2020 in the Journal of the American Chemical Society
  • From Carbodiimides to Carbon Dioxide: Quantification of the Electrophilic Reactivities of Heteroallenes, published in 2020 in the Journal of the American Chemical Society
  • Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial, published in 2020 in UNC Libraries
  • Lewis Acidic Boranes, Lewis Bases, and Equilibrium Constants: A Reliable Scaffold for a Quantitative Lewis Acidity/Basicity Scale, published in 2020 in Chemistry - A European Journal

The list of frequent coauthors who have collaborated with Mayer multiple times includes:

  • Armin R. Ofial
  • Donna Niedzwiecki
  • Richard M. Goldberg
  • Alan P. Venook
  • Jeffrey A. Meyerhardt

Publication venues where Mayer's work frequently appears include:

  • The Cambridge Structural Database
  • Journal of Clinical Oncology
  • UNC Libraries
  • Angewandte Chemie
  • Angewandte Chemie International Edition

Best Publications

  • Colorectal cancer screening: Clinical guidelines and rationale

    SJ Winawer;RH Fletcher;L Miller;F Godlee

  • Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

    John C. Byrd;Krzysztof Mrózek;Richard K. Dodge;Andrew J. Carroll

  • Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor Receptor

    Leonard B. Saltz;Neal J. Meropol;Patrick J. Loehrer;Michael N. Needle

  • Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B

    Mayer Rj;Davis Rb;Schiffer Ca;Berg Dt

  • Systemic Therapy for Colorectal Cancer

    Jeffrey A. Meyerhardt;Robert J. Mayer

  • Phase III Trial of Trimodality Therapy With Cisplatin, Fluorouracil, Radiotherapy, and Surgery Compared With Surgery Alone for Esophageal Cancer: CALGB 9781

    Joel Tepper;Mark J. Krasna;Donna Niedzwiecki;Donna Hollis

  • Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

    Robert J Mayer;Eric Van Cutsem;Alfredo Falcone;Takayuki Yoshino

  • Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery

    Michael J. O'Connell;James A. Martenson;Harry S. Wieand;James E. Krook

  • Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089

    T.E. Le Voyer;E.R. Sigurdson;A.L. Hanlon;R.J. Mayer

  • National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.

    Eifel P;Axelson Ja;Costa J;Crowley J

  • Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)

    Hedy Lee Kindler;Donna Niedzwiecki;Donna Hollis;Susan Sutherland

  • Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal: A Randomized Controlled Trial

    Jaffer A. Ajani;Kathryn A. Winter;Leonard L. Gunderson;John Pedersen

  • Frequency of Prolonged Remission Duration after High-Dose Cytarabine Intensification in Acute Myeloid Leukemia Varies by Cytogenetic Subtype

    Clara D. Bloomfield;David Lawrence;John C. Byrd;Andrew Carroll

  • Impact of Physical Activity on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803

    Jeffrey A. Meyerhardt;Denise Heseltine;Donna Niedzwiecki;Donna Hollis

  • Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

    Alan P. Venook;Donna Niedzwiecki;Heinz Josef Lenz;Federico Innocenti

  • Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer.

    M J O'Connell;J A Mailliard;M J Kahn;J S Macdonald

  • Impact of Number of Nodes Retrieved on Outcome in Patients With Rectal Cancer

    Joel E. Tepper;Michael J. O’Connell;Donna Niedzwiecki;Donna Hollis

  • The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group.

    N Petrelli;H O Douglass;L Herrera;D Russell

  • Survival after postoperative combination treatment of rectal cancer.

    Douglass Ho;Moertel Cg;Mayer Rj;Thomas Pr

  • Chemoprevention of colorectal cancer.

    Pasi A. Jänne;Robert J. Mayer

Frequent Co-Authors

Donna Niedzwiecki
Donna Niedzwiecki Duke University
Jeffrey A. Meyerhardt
Jeffrey A. Meyerhardt Harvard University
Alan P. Venook
Alan P. Venook University of California, San Francisco
Monica M. Bertagnolli
Monica M. Bertagnolli Brigham and Women's Hospital
Al B. Benson
Al B. Benson Northwestern University
Richard M. Goldberg
Richard M. Goldberg West Virginia University
Leonard Saltz
Leonard Saltz Memorial Sloan Kettering Cancer Center
Howard S. Hochster
Howard S. Hochster Yale University
Heinz-Josef Lenz
Heinz-Josef Lenz University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in Medicine but want to explore flexible or alternative pathways, online degrees can open exciting doors. Many choose nursing as an entry point, often starting out with the fastest LPN program to quickly qualify for healthcare positions and gain hands-on experience.

For those interested in advanced practice and mental health, the fastest psychiatric nurse practitioner program offers a quick path to specialized roles, helping you make a difference in psychiatric care.

Beyond clinical work, many students shift their focus to healthcare management. With a health care administration degree online, you can prepare for leadership roles, often while balancing work and study.

Considering cost is important, especially for master’s programs. Be sure to compare options and understand the cost of MHA degree programs to ensure your investment aligns with your career goals.

Best Scientists Citing Robert J. Mayer

Trending Scientists

Recently Published Articles